XXII(XXII)
XXII
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E |
|---|---|
| Revenue Avg | $33M |
| Low | $33M |
| High | $33M |
| EBITDA Avg | $-31M |
| Low | $-31M |
| High | $-31M |
| EBIT Avg | $-32M |
| Low | $-32M |
| High | $-32M |
| Net Income Avg | $-3M |
| Low | $-3M |
| High | $-3M |
| EPS Avg | $-18.00 |
| Low | $-18.00 |
| High | $-18.00 |
| Analysts (Rev / EPS) | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $8M | $12M |
| Low | $8M | $12M |
| High | $8M | $12M |
| EBITDA Avg | $-8M | $-12M |
| Low | $-8M | $-12M |
| High | $-8M | $-12M |
| EBIT Avg | $-8M | $-12M |
| Low | $-8M | $-12M |
| High | $-8M | $-12M |
| Net Income Avg | $-2M | $9M |
| Low | $-2M | $9M |
| High | $-2M | $9M |
| EPS Avg | $-3.00 | $15.00 |
| Low | $-3.00 | $15.00 |
| High | $-3.00 | $15.00 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |